What the New Dupixent MDL Means for Patients Diagnosed With CTCL
Learn what MDL No. 3180 means, what the transfer to the District of New Jersey does not decide, and what may happen next.
Read ArticleDupixent CTCL Resources
Focused resources on Dupixent, CTCL, related T-cell lymphoma diagnoses, litigation updates, and information that may matter before an initial case review.
Was Dupixent Prescribed for Eczema Before a CTCL Diagnosis?
Learn why CTCL can sometimes resemble eczema, why Dupixent treatment history may matter, and what records may help clarify the timeline.
Read ArticleWhat If CTCL Was Diagnosed After Stopping Dupixent?
Learn why timing may matter after stopping Dupixent and what information may help clarify the treatment and diagnosis sequence.
Read ArticleDupixent and Mycosis Fungoides Lawsuit Review
Understand why mycosis fungoides may matter in Dupixent CTCL case review, how it can resemble eczema or dermatitis, and what records may be relevant before requesting an initial review.
Read ArticleDupixent and Sézary Syndrome Lawsuit Review
Learn why Sézary syndrome may matter in Dupixent CTCL case review, what information may be relevant, and how diagnosis timing and records can affect an initial review.
Read ArticleDupixent and T-Cell Lymphoma Case Review Factors
Review records that may help explain diagnosis, timing, Dupixent treatment history, and whether follow-up may be appropriate.
Read ArticleStart Free Case Review
If you used Dupixent and were later diagnosed with CTCL or another related T-cell lymphoma, you may submit basic information for focused initial review.